Annual Operating Profit
-$1.83 M
+$17.60 M+90.57%
01 December 2023
Summary:
Altamira Therapeutics annual operaing income is currently -$1.83 million, with the most recent change of +$17.60 million (+90.57%) on 01 December 2023. During the last 3 years, it has risen by +$4.21 million (+69.70%). CYTO annual operating profit is now at all-time high.CYTO Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
N/A
01 June 2024
Summary:
Altamira Therapeutics quarterly operating income is not available.CYTO Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
N/A
01 June 2024
Summary:
Altamira Therapeutics TTM operating income is not available.CYTO TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYTO Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +69.7% | - | - |
| 5 y5 years | +83.5% | - | - |
CYTO Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +90.6% | ||||
| 5 y | 5 years | at high | +90.6% | ||||
| alltime | all time | at high | +94.1% |
Altamira Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$1.83 M(-90.6%) | - | - |
| Dec 2022 | -$19.43 M(+158.5%) | - | - |
| Dec 2021 | -$7.52 M(+24.3%) | - | - |
| Dec 2020 | -$6.05 M(-19.3%) | - | - |
| Dec 2019 | -$7.49 M(-32.7%) | - | - |
| Dec 2018 | -$11.13 M(-55.5%) | -$646.40 K(-77.9%) | -$11.20 M(-30.6%) |
| Sept 2018 | - | -$2.92 M(-6.4%) | -$16.15 M(-14.7%) |
| June 2018 | - | -$3.12 M(-30.9%) | -$18.93 M(-14.1%) |
| Mar 2018 | - | -$4.51 M(-19.3%) | -$22.05 M(-11.6%) |
| Dec 2017 | -$25.01 M(-15.7%) | -$5.59 M(-1.9%) | -$24.93 M(+2.8%) |
| Sept 2017 | - | -$5.70 M(-8.6%) | -$24.26 M(-8.0%) |
| June 2017 | - | -$6.24 M(-15.8%) | -$26.37 M(-10.1%) |
| Mar 2017 | - | -$7.40 M(+50.4%) | -$29.32 M(-0.8%) |
| Dec 2016 | -$29.66 M | -$4.92 M(-36.9%) | -$29.55 M(-4.8%) |
| Sept 2016 | - | -$7.81 M(-15.1%) | -$31.05 M(+1.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2016 | - | -$9.19 M(+20.5%) | -$30.67 M(-4.1%) |
| Mar 2016 | - | -$7.63 M(+18.7%) | -$31.98 M(+0.7%) |
| Dec 2015 | -$31.24 M(+44.5%) | -$6.43 M(-13.4%) | -$31.75 M(+7.6%) |
| Sept 2015 | - | -$7.42 M(-29.3%) | -$29.50 M(+5.2%) |
| June 2015 | - | -$10.51 M(+42.0%) | -$28.05 M(+20.9%) |
| Mar 2015 | - | -$7.40 M(+77.4%) | -$23.21 M(+3.5%) |
| Dec 2014 | -$21.61 M(+31.2%) | -$4.17 M(-30.2%) | -$22.41 M(+1.0%) |
| Sept 2014 | - | -$5.98 M(+5.6%) | -$22.19 M(+4.6%) |
| June 2014 | - | -$5.66 M(-14.3%) | -$21.21 M(+2.4%) |
| Mar 2014 | - | -$6.61 M(+67.3%) | -$20.71 M(+25.8%) |
| Dec 2013 | -$16.47 M(+226.1%) | -$3.95 M(-20.9%) | -$16.47 M(+31.5%) |
| Sept 2013 | - | -$4.99 M(-3.4%) | -$12.52 M(+66.3%) |
| June 2013 | - | -$5.17 M(+118.9%) | -$7.53 M(+218.9%) |
| Mar 2013 | - | -$2.36 M | -$2.36 M |
| Dec 2012 | -$5.05 M | - | - |
FAQ
- What is Altamira Therapeutics annual operaing income?
- What is the all time high annual operating profit for Altamira Therapeutics?
- What is the all time high quarterly operating profit for Altamira Therapeutics?
- What is the all time high TTM operating profit for Altamira Therapeutics?
What is Altamira Therapeutics annual operaing income?
The current annual operating profit of CYTO is -$1.83 M
What is the all time high annual operating profit for Altamira Therapeutics?
Altamira Therapeutics all-time high annual operaing income is -$1.83 M
What is the all time high quarterly operating profit for Altamira Therapeutics?
Altamira Therapeutics all-time high quarterly operating income is -$646.40 K
What is the all time high TTM operating profit for Altamira Therapeutics?
Altamira Therapeutics all-time high TTM operating income is -$2.36 M